JESSICA THOMPSON: Open Payments
NPI 1174161491 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,685 in 71 payments from 9 companies in 2025. Trend: 2023 $2,145 · 2024 $1,370 · 2025 $1,685
Food & beverage: $1,685
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $424 |
| Janssen Pharmaceuticals, Inc | 15 | $408 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $297 |
| Otsuka America Pharmaceutical, Inc. | 5 | $181 |
| Teva Pharmaceuticals USA, Inc. | 14 | $174 |
| Neurocrine BioSciences, Inc. | 2 | $61 |
| Alkermes, Inc. | 3 | $55 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $40 |
Products named: COBENFY, INVEGA SUSTENNA, CAPLYTA, REXULTI, UZEDY, AUSTEDO XR, INGREZZA, ARISTADA.
Industry payments across TX — which companies pay providers there.
